Skip to main content

Vystar Corp

corporate_fare Company Profile

Vystar Corp

VYST·OTC·Manufacturing·CIK 0001308027

Vystar Corporation, based in Worcester, Massachusetts, is an owner and manufacturer of eco-friendly products for the home, office, and medical sectors. The company focuses on three main brands: Vytex, RXAIR, and Fluid Energy Conversion (FEC). Vystar previously held a majority ownership in Murida Furniture Co., Inc. dba Rotmans Furniture, an independent furniture retailer, but all activities of Rotmans are now included in discontinued operations. Vystar is the creator and exclusive owner of the technology for Vytex® Natural Rubber Latex (NRL). This global multi-patented technology reduces antigenic and total protein in natural rubber latex products to virtually undetectable levels. Vytex NRL, an "ultra-low protein" natural rubber latex, is used worldwide as a raw material in products such as balloons, foams, textiles, adhesives, carpet, paints, coatings, protective equipment, sporting equipment, and healthcare products like surgical and exam gloves and condoms. Vystar has also expanded Vytex into consumer bedding products, including mattresses, mattress toppers, and pillows, through partnerships with foam manufacturers. Vystar also operates in the clean-air space with RxAir, a manufacturer of air purification systems and a developer, manufacturer, and distributor of biotechnology products for the Indoor Air Quality (IAQ) industry. RxAir's products include the RxAir purification system for homes and hospital-grade HEPA filtration products. All RxAir products are FDA certified as Class II medical devices and are designed to kill germs, viruses, and bacteria.

Vystar Corp (OTC:VYST) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 6 items for VYST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for VYST spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Vystar 10-Q Reveals Going Concern, Material Weaknesses, and Quantifies r3alm JV Terms
  • Vystar Completes R3ALM Acquisition, Eyes $120M Tokenized Equity Launch
  • Vystar Takes 50% of AI/Web3 Fintech r3alm, Hands Capital Realm a 34% Stake
  • Vystar Reports Continued Going Concern Doubt, Material Weaknesses, and Announces Major Web3 Strategic Pivot
  • Vystar's 2025 Revenue Plummets 60% to $54.8K, Reports $1.53M Net Loss

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$54.82K
Net Income
-$1.53M
Op. Cash Flow
-$180.39K
Gross Profit
$31.82K
Operating Income
-$1.06M
Cash & Equivalents
$4.45K
Debt / Equity
0.00×
Net Margin
-27.94×
Shares Outstanding
24.62M sh
Source: 10-K · filed 2026-04-15 · accession 0001493152-26-016763
Browse all tickers starting with V →
$0.0947 -0.00% today
52-week range · as of 2026-08-13 $0.0167 – $0.37
Market cap
$2.33M
Volume
4.3K (0.1× avg)
3-mo avg 41.4K
Live data · 2026-10-05 02:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed VYST - Latest Insights

VYST
Aug 13, 2026, 3:27 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.100
Real-time Price: $0.0947 info
Change: -$0.0053 (-5%) info
Market Cap: $2.332M info
VYST
Aug 10, 2026, 8:17 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.100
Real-time Price: $0.0947 info
Change: -$0.0053 (-5%) info
Market Cap: $2.332M info
VYST
Aug 06, 2026, 8:29 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.115
Real-time Price: $0.0947 info
Change: -$0.0203 (-18%) info
Market Cap: $2.332M info
VYST
May 12, 2026, 6:26 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.1443
Real-time Price: $0.0947 info
Change: -$0.0496 (-34%) info
Market Cap: $2.332M info
VYST
Apr 15, 2026, 2:35 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.2507
Real-time Price: $0.0947 info
Change: -$0.156 (-62%) info
Market Cap: $2.332M info
VYST
Apr 15, 2026, 2:25 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.2507
Real-time Price: $0.0947 info
Change: -$0.156 (-62%) info
Market Cap: $2.332M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets